Wij zijn onze website aan het vernieuwen.

Ontdekt u nog een pagina die niet klopt of hebt u een goede suggestie, laat het ons dan weten via webmedia@umcutrecht.nl.

Deze website maakt gebruik van cookies

Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Lees meer over het cookiebeleid.

dr. E.F. Knol Associate Professor

  • Laboratory for Translational Immunology (LTI)
  • Laboratory for Translational Immunology (LTI)
  • Dermatology and Allergology
  • Dermatology and Allergology

E.F. Knol

Contact

Research Programs

Biography

Edward Knol is a biomedical scientist and immunologist in the departments of Immunology and Dermatology/Allergology at the University Medical Center Utrecht. He did his PhD training in the Blood Transfusion Service of the University of Amsterdam and had a postdoc position at Johns Hopkins University in Baltimore. His scientific research focuses on allergic diseases, in particularly eczema and food allergy. The research focusses on 1) improved insights in pathomechanisms, 2) explore new treatment options, 3) improve current diagnostics and establish new diagnostics platforms. In his career Edward Knol discovered CD63 as the basophil activation marker, described the important role of the peanut allergen Ara h 2 and described A20/TNFAIP3 dysregulation in atopic dermatitis. He is involved in several (inter)national collaborations and is Secretary General of the Dutch Society of Immunology (~1400 members).

Within the University Medical Center he holds a teaching position and chairs the education committee of the University Utrecht graduate school Immunity and Infection (50 master and 170 PhD students). He is coordinator and examiner of: 1) Course Clinical Immunology for 3rd years students Biomedical Sciences, 2) Course Immune Therapy for 2nd years student Medicine and 3) Course Infection and Immunity for 3rd years Students at the Technical University Eindhoven. 

At the international level Edward Knol has organised 3 European Academy of Allergy and Clinical Immunology (EAACI) Winter schools and was the chair of the Scientific Program Committee of the EAACI annual meetings in 2014-2016. In addition, since 2019 he is Vice President Congresses of EAACI. 

Specialties: Immunology, Allergy, Food Allergy, Atopic Dermatitis, Basophilic granulocytes, T lymphocytes, allergy diagnostic tests, basophil activation test

Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=Knol%20EF%5BAuthor%5D&cauthor=true&cauthor_uid=26198455

 

Google Scholar:  http://scholar.google.com/citations?hl=en&user=nfo_25cAAAAJ

Scopus H-factor: h-index: 51

Research gate: h-index: 54, : RG score: 46,95

Google Scholar: h-index: 60 

 

Side Activities

  • 2009- Chair Educational committee Master and PhD program Graduate School Immunity and Infection, University van Utrecht. Supervising the training program of 50 Master students and 180 PhD students.

    2013- Co-director FOCIS Center of Excellence, Utrecht Infection and Immunity Center.

    2014- Member taskforce IgE diagnostics, EAACI

    2015- Member guideline committee Allergy Immunotherapy, EAACI

    2015-2018 Steering committee member FOCIS, representing EAACI

    2014-2016 Chair Scientific Program Committee (SPC) EAACI, coordinating EAACI annual meetings in 2015 (Barcelona) and 2016 (Vienna).

    2019- Vice President EAACI Congresses and Events, coordinating all scientific meetings of European Academy of Allergy and Clinical Immunology ranging from 8500 participants to 280 participants per meeting

     

    Editorial Board memberships:

    - Dutch Journal for Allergology

    - Clinical and Translational Allergy

    - Clinical and Experimental Allergy

     

     

     

Research Output (229)

Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry

Ariens Lieneke F. M., van der Schaft Jorien, Bakker Daphne S., Balak Deepak, Romeijn Margreet L. E., Kouwenhoven Tessa, Kamsteeg Marijke, Giovannone Barbara, Drylewicz Julia, van Amerongen Cynthia Catalina Aurora, Delemarre Evelien M., Knol Edward F., van Wijk Femke, Nierkens Stefan, Thijs Judith L., Schuttelaar Marie L. A., de Bruin-Weller Marjolein S. 1 jan 2020, In: Allergy. 75 , p. 116-126 11 p.

Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment

Bakker Daphne S., Drylewicz Julia, Nierkens Stefan, Knol Edward F., Giovannone Barbara, Delemarre Eveline M., van der Schaft Jorien, Balak Deepak M.W., de Bruin-Weller Marjolein S., Thijs Judith L. dec 2019, In: Clinical and Experimental Allergy. 49 , p. 1641-1644 4 p.

Management of Cow's Milk Allergy from an Immunological Perspective:What Are the Options?

Knol Edward F, Jong Nicolette W de, Ulfman Laurien H, Tiemessen Machteld M 11 nov 2019, In: Nutrients. 11 8 p.

Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity

Thijs Judith L., Fiechter Renée, Giovannone Barbara, de Bruin-Weller Marjolein S., Knol Edward F., Bruijnzeel-Koomen Carla A.F.M., Drylewicz Julia, Nierkens Stefan, Hijnen Dirk Jan nov 2019, In: Allergy: European Journal of Allergy and Clinical Immunology. 74 , p. 2240-2243 4 p.

Predicting treatment response to methotrexate in atopic dermatitis patients using clinical characteristics and serum biomarkers

Ariens L., Thijs J., Bakker D., Drylewicz J., Nierkens Stefan, Knol E., Delemarre E., Balak D., van der Schaft J., de Bruin-Weller M. sep 2019, In: Journal of Investigative Dermatology. 139 , p. S287-S287

Endotyping of adult and paediatric atopic dermatitis; is it one disease?

Thijs J., Bakker D., Delemarre E., de Graaf M., Knol E., Drylewicz J., van Wijk F., Nierkens S., de Bruin-Weller M. sep 2019, In: Journal of Investigative Dermatology. 139 , p. S285-S285

Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment

Bakker D., Drylewicz J., Nierkens S., Knol E., van der Schaft J., Delemarre E., Balak D., de Bruin-Weller M., Thijs J. sep 2019, In: Journal of Investigative Dermatology. 139 , p. S286-S286

Ophthalmological characteristics and treatment outcomes of conjunctivitis in patients receiving dupilumab for moderate-to-severe atopic dermatitis

Lans A., Van Luijk C. M., Bakker D. S., Ariens L. F. M., Thijs J. L., Van der Schaft J., De Boer J. H., Knol E. F., De Bruin-Weller M. S., Balak D. M. W. aug 2019, In: Allergy. 74 , p. 714-714

Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria:Results of the PURIST Study

Schoepke Nicole, Asero Riccardo, Ellrich André, Ferrer Marta, Gimenez-Arnau Ana, Grattan Clive E H, Jakob Thilo, Konstantinou George N, Raap Ulrike, Skov Per Stahl, Staubach Petra, Kromminga Arno, Zhang Ke, Bindslev-Jensen Carsten, Daschner Alvaro, Kinaciyan Tamar, Knol Edward F, Makris Michael, Marrouche Nadine, Schmid-Grendelmeier Peter, Sussman Gordon, Toubi Elias, Church Martin K, Maurer Marcus 22 jun 2019, In: Allergy. 74 , p. 2427-2436 10 p.

Pegvaliase:Immunological profile and recommendations for the clinical management of hypersensitivity reactions in patients with phenylketonuria treated with this enzyme substitution therapy

Hausmann Oliver, Daha Mohamed, Longo Nicola, Knol Edward, Müller Ingo, Northrup Hope, Brockow Knut 17 jun 2019, In: Molecular Genetics and Metabolism. 128 , p. 84-91 8 p.

All Research Output (229)
To top